BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 25479686)

  • 21. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
    Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
    Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes.
    Diep CH; Ahrendt H; Lange CA
    Steroids; 2016 Oct; 114():48-58. PubMed ID: 27641443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p42/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth.
    Tkach M; Rosemblit C; Rivas MA; Proietti CJ; Díaz Flaqué MC; Mercogliano MF; Beguelin W; Maronna E; Guzmán P; Gercovich FG; Deza EG; Elizalde PV; Schillaci R
    Endocr Relat Cancer; 2013 Apr; 20(2):197-212. PubMed ID: 23329648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-Stimulated Genes Are Transcriptionally Repressed by PR in Breast Cancer.
    Walter KR; Goodman ML; Singhal H; Hall JA; Li T; Holloran SM; Trinca GM; Gibson KA; Jin VX; Greene GL; Hagan CR
    Mol Cancer Res; 2017 Oct; 15(10):1331-1340. PubMed ID: 28684637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors.
    Faivre EJ; Daniel AR; Hillard CJ; Lange CA
    Mol Endocrinol; 2008 Apr; 22(4):823-37. PubMed ID: 18202149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GATA3 protein as a MUC1 transcriptional regulator in breast cancer cells.
    Abba MC; Nunez MI; Colussi AG; Croce MV; Segal-Eiras A; Aldaz CM
    Breast Cancer Res; 2006; 8(6):R64. PubMed ID: 17078870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.
    Le Bihan S; Marsaud V; Mercier-Bodard C; Baulieu EE; Mader S; White JH; Renoir JM
    Mol Endocrinol; 1998 Jul; 12(7):986-1001. PubMed ID: 9658403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclin A2 and its associated kinase activity are required for optimal induction of progesterone receptor target genes in breast cancer cells.
    Moore NL; Edwards DP; Weigel NL
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B(0 0):471-82. PubMed ID: 25220500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs.
    Knutson TP; Truong TH; Ma S; Brady NJ; Sullivan ME; Raj G; Schwertfeger KL; Lange CA
    J Hematol Oncol; 2017 Apr; 10(1):89. PubMed ID: 28412963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and mutational analysis of GATA3 in Malaysian breast carcinomas.
    Bong PN; Zakaria Z; Muhammad R; Abdullah N; Ibrahim N; Emran NA; Syed Hussain SN
    Malays J Pathol; 2010 Dec; 32(2):117-22. PubMed ID: 21329183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells.
    Hagan CR; Regan TM; Dressing GE; Lange CA
    Mol Cell Biol; 2011 Jun; 31(12):2439-52. PubMed ID: 21518957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.
    Murphy LC; Dotzlaw H; Wong MS; Miller T; Murphy LJ
    Cancer Res; 1991 Apr; 51(8):2051-7. PubMed ID: 1849041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progesterone receptor directly inhibits β-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications.
    Buser AC; Obr AE; Kabotyanski EB; Grimm SL; Rosen JM; Edwards DP
    Mol Endocrinol; 2011 Jun; 25(6):955-68. PubMed ID: 21527503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
    Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV
    Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer.
    Cohen H; Ben-Hamo R; Gidoni M; Yitzhaki I; Kozol R; Zilberberg A; Efroni S
    Breast Cancer Res; 2014 Nov; 16(6):464. PubMed ID: 25410484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNPC1 enhances progesterone receptor functions by regulating its mRNA stability in breast cancer.
    Lou P; Li C; Shi L; Xia TS; Zhou W; Wu J; Zhou X; Li X; Wang Y; Wei JF; Ding Q
    Oncotarget; 2017 Mar; 8(10):16387-16400. PubMed ID: 27634883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression.
    Knutson TP; Daniel AR; Fan D; Silverstein KA; Covington KR; Fuqua SA; Lange CA
    Breast Cancer Res; 2012 Jun; 14(3):R95. PubMed ID: 22697792
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Shahi P; Wang CY; Lawson DA; Slorach EM; Lu A; Yu Y; Lai MD; Gonzalez Velozo H; Werb Z
    Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3169-3174. PubMed ID: 28258171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of fibroblast growth factor-8b target genes associated with early and late cell cycle events in breast cancer cells.
    Nilsson EM; Brokken LJ; Narvi E; Kallio MJ; Härkönen PL
    Mol Cell Endocrinol; 2012 Jul; 358(1):104-15. PubMed ID: 22465097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cells.
    Hagan CR; Knutson TP; Lange CA
    Nucleic Acids Res; 2013 Oct; 41(19):8926-42. PubMed ID: 23921636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.